Overview Financials News + Filings Key Docs Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Quarterly results
|
Tarsus Pharmaceuticals, Inc.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
04/26/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/11/2022 |
3
| Morrison Scott W (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
01/04/2022 |
3
| Lin Elizabeth Yeu (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
08/12/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/21/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/08/2021 |
3
| Whitfield Dianne C. (Chief Human Resources Officer) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
11/23/2020 |
3
| YARNO WENDY L (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/26/2020 |
3
| RTW INVESTMENTS, LP (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Frazier Life Sciences IX, L.P. (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Horowitz Limited Partnership VIII (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Vivo Capital IX, LLC (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| LINK WILLIAM J PHD (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Tester Jason E. (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| CHAUDHURI BHASKAR (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Goldberg Andrew D. (Director) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Ackermann Michael (10% Owner) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Holdbrook Mark J. (V.P., Clinical Affairs) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Mottiwala Aziz (Chief Commercial Officer) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Neervannan Seshadri (COO) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Greenstein Leonard M. (CFO) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
10/15/2020 |
3
| Azamian Bobak R. (President and CEO) has filed a Form 3 on Tarsus Pharmaceuticals, Inc. |
|
|